Journal of Applied Physiology Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 58: 534-543, 1985;
8750-7587/85 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, K. M.
Right arrow Articles by Fregly, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, K. M.
Right arrow Articles by Fregly, M. J.

Journal of Applied Physiology, Vol 58, Issue 2 534-543, Copyright © 1985 by American Physiological Society


ARTICLES

Angiotensin II-induced hypothermia in rats

K. M. Wilson and M. J. Fregly

Systemic administration of angiotensin II (ANG II) (200 micrograms/kg sc) to the rat induced a hypothermic response that was characterized within 12 min by a reduction in the rate of O2 consumption, vasodilation of the tail, and a 1.3 degrees C fall in colonic temperature. Administration of ANG II in doses ranging from 10 to 200 micrograms/kg resulted in a decrease in colonic and an increase in tail skin temperature. Angiotensin I (ANG I) (200 micrograms/kg sc) induced a similar hypothermic response which was abolished by pretreatment with the ANG I-converting enzyme inhibitor, captopril (35 mg/kg ip). The interaction of ANG II with cholinergic and adrenergic pathways was evaluated to determine possible mechanisms. Treatment with ANG II (200 micrograms/kg sc) and propranolol, a beta-adrenoceptor antagonist (6 mg/kg ip), resulted in a greater depression of colonic temperature (Tco) than was observed with ANG II alone but did not affect the increase in tail skin temperature (Tsk) accompanying administration of ANG II. When ANG II was administered in combination with the beta-adrenergic agonist, isoproterenol (50 micrograms/kg ip), Tco remained at control levels, whereas an enhancement of the ANG II-induced increase in Tsk occurred. Administration of ANG II in combination with atropine sulfate (6 mg/kg ip), a muscarinic receptor antagonist which crosses the blood-brain barrier, significantly reduced the extent of the fall in Tco without affecting the increase in Tsk. The combined treatment of ANG II and the quaternary analogue, atropine methyl nitrate (3.25 mg/kg ip), which does not cross the blood-brain barrier, failed to affect the hypothermic responses to ANG II. These results suggest that the hypothermic responses to ANG II may be mediated through a central cholinergic pathway and possibly influenced by an adrenergic component. The inability of both adrenergic and cholinergic blockers to affect the vasodilatory response of the tail of the rat to administration of ANG II suggests that the mechanisms subserving heat production can be blocked independently of those subserving heat loss.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. H. R. Leite, A. C. R. Lacerda, U. Marubayashi, and C. C. Coimbra
Central angiotensin AT1-receptor blockade affects thermoregulation and running performance in rats
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R603 - R607.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
J. Grobe, N. Rowland, and M. Katovich
ROLE OF ANGIOTENSIN II AND THE SUBFORNICAL ORGAN IN THE PHARMACOLOGICAL ACTIONS OF ETHANOL
Alcohol Alcohol., September 1, 2004; 39(5): 410 - 417.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Cassis, M. Helton, V. English, and G. Burke
Angiotensin II regulates oxygen consumption
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R445 - R453.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. L. Mathai, T. Hubschle, and M. J. McKinley
Central angiotensin receptor blockade impairs thermolytic and dipsogenic responses to heat exposure in rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2000; 279(5): R1821 - R1826.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Watanabe, M. Hashimoto, M. Wada, T. Imoto, M. Miyoshi, D. Sadamitsu, and T. Maekawa
Angiotensin-converting enzyme inhibitor inhibits dehydration-enhanced fever induced by endotoxin in rats
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1512 - R1516.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. A. Cassis, D. E. Marshall, M. J. Fettinger, B. Rosenbluth, and R. A. Lodder
Mechanisms contributing to angiotensin II regulation of body weight
Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E867 - E876.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online